Insider · CIK 0001822140

Voermann Karsten

Reports to the SEC for 1 company · SANTA MONICA, CA

sec.gov

Transactions

Companies

Filings

CIK

0001822140

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-01-08	GDRXGoodRx Holdings, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+89.3K sh	—	—	392,596
2025-01-08	GDRXGoodRx Holdings, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−29K sh	$4.41	−$128K	363,561
2025-01-08	GDRXGoodRx Holdings, Inc. · Restricted Stock UnitM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−89.3K sh	—	—	267,876
2024-12-08	GDRXGoodRx Holdings, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+54.1K sh	—	—	327,963
2024-12-08	GDRXGoodRx Holdings, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−24.7K sh	$4.91	−$121K	303,304
2024-12-08	GDRXGoodRx Holdings, Inc. · Restricted Stock UnitM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−54.1K sh	—	—	378,448
2024-09-08	GDRXGoodRx Holdings, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+54.1K sh	—	—	298,599
2024-09-08	GDRXGoodRx Holdings, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−24.7K sh	$7.71	−$190K	273,899
2024-09-08	GDRXGoodRx Holdings, Inc. · Restricted Stock UnitM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−54.1K sh	—	—	432,512
2024-06-08	GDRXGoodRx Holdings, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+54.1K sh	—	—	266,016
2024-06-08	GDRXGoodRx Holdings, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−21.5K sh	$8.55	−$184K	244,535
2024-06-08	GDRXGoodRx Holdings, Inc. · Restricted Stock UnitM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−54.1K sh	—	—	486,576
2024-03-12	GDRXGoodRx Holdings, Inc. · Restricted Stock UnitA Award	Chief Financial Officer	AAward	+357K sh	—	—	357,168
2024-03-12	GDRXGoodRx Holdings, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+516K sh	—	—	515,793
2024-03-08	GDRXGoodRx Holdings, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+54.1K sh	—	—	229,192
2024-03-08	GDRXGoodRx Holdings, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−17.2K sh	$7.54	−$130K	211,952
2024-03-08	GDRXGoodRx Holdings, Inc. · Restricted Stock UnitM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−54.1K sh	—	—	540,640
2023-12-08	GDRXGoodRx Holdings, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+54.1K sh	—	—	199,885
2023-12-08	GDRXGoodRx Holdings, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−24.8K sh	$5.94	−$147K	175,128
2023-12-08	GDRXGoodRx Holdings, Inc. · Restricted Stock UnitM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−54.1K sh	—	—	594,704
2023-09-08	GDRXGoodRx Holdings, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+54.1K sh	—	—	165,578
2023-09-08	GDRXGoodRx Holdings, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−19.8K sh	$6.16	−$122K	145,821
2023-09-08	GDRXGoodRx Holdings, Inc. · Restricted Stock UnitM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−54.1K sh	—	—	648,768
2023-06-08	GDRXGoodRx Holdings, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+54.1K sh	—	—	128,125
2023-06-08	GDRXGoodRx Holdings, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−16.6K sh	$5.41	−$89.9K	111,514
2023-06-08	GDRXGoodRx Holdings, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−54.1K sh	—	—	702,832
2023-03-08	GDRXGoodRx Holdings, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+54.1K sh	—	—	91,458
2023-03-08	GDRXGoodRx Holdings, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−17.4K sh	$5.50	−$95.7K	74,061
2023-03-08	GDRXGoodRx Holdings, Inc. · Restricted Stock UnitM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−54.1K sh	—	—	756,896
2022-12-08	GDRXGoodRx Holdings, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+54.1K sh	—	—	54,063
2022-12-08	GDRXGoodRx Holdings, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−16.7K sh	$4.98	−$83K	37,394
2022-12-08	GDRXGoodRx Holdings, Inc. · Restricted Stock UnitM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−54.1K sh	—	—	810,960
2022-09-22	GDRXGoodRx Holdings, Inc. · Restricted Stock UnitA Award	Chief Financial Officer	AAward	+865K sh	—	—	865,023
2021-12-28	GDRXGoodRx Holdings, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+12.5K sh	$6.84	+$85.5K	12,500
2021-12-28	GDRXGoodRx Holdings, Inc.S Sale	Chief Financial Officer	SSale	−12.5K sh	$33.05	−$413K	0
2021-12-28	GDRXGoodRx Holdings, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−12.5K sh	—	—	342,500
2021-12-01	GDRXGoodRx Holdings, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+12.5K sh	$6.84	+$85.5K	12,500
2021-12-01	GDRXGoodRx Holdings, Inc.S Sale	Chief Financial Officer	SSale	−4,189 sh	$38.35	−$161K	8,311
2021-12-01	GDRXGoodRx Holdings, Inc.S Sale	Chief Financial Officer	SSale	−2,200 sh	$39.31	−$86.5K	6,111
2021-12-01	GDRXGoodRx Holdings, Inc.S Sale	Chief Financial Officer	SSale	−6,111 sh	$40.22	−$246K	0
2021-12-01	GDRXGoodRx Holdings, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−12.5K sh	—	—	355,000
2021-11-01	GDRXGoodRx Holdings, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+12.5K sh	$6.84	+$85.5K	12,500
2021-11-01	GDRXGoodRx Holdings, Inc.S Sale	Chief Financial Officer	SSale	−12.3K sh	$44.04	−$542K	200
2021-11-01	GDRXGoodRx Holdings, Inc.S Sale	Chief Financial Officer	SSale	−200 sh	—	—	0
2021-11-01	GDRXGoodRx Holdings, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−12.5K sh	—	—	367,500
2021-09-28	GDRXGoodRx Holdings, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+7,500 sh	$6.84	+$51.3K	7,500
2021-09-28	GDRXGoodRx Holdings, Inc.S Sale	Chief Financial Officer	SSale	−7,000 sh	$40.22	−$282K	500
2021-09-28	GDRXGoodRx Holdings, Inc.S Sale	Chief Financial Officer	SSale	−500 sh	$41.52	−$20.8K	0
2021-09-28	GDRXGoodRx Holdings, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−7,500 sh	—	—	380,000
2021-08-30	GDRXGoodRx Holdings, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+12.5K sh	$6.84	+$85.5K	12,500

Recent filings

Accepted (ET)
Jan 84
Voermann Karsten0001809519-25-000008
SEC(opens sec.gov)
Dec 94
Voermann Karsten0001809519-24-000208
SEC(opens sec.gov)
Sep 94
Voermann Karsten0001809519-24-000177
SEC(opens sec.gov)
Jun 104
Voermann Karsten0001809519-24-000106
SEC(opens sec.gov)
Mar 144
Voermann Karsten0001809519-24-000049
SEC(opens sec.gov)
Mar 84
Voermann Karsten0001809519-24-000043
SEC(opens sec.gov)
Dec 84
Voermann Karsten0001809519-23-000057
SEC(opens sec.gov)

Companies

GoodRx Holdings, Inc.Chief Financial OfficerGDRX

Address

C/O GOODRX HOLDINGS, INC. 2701 OLYMPIC BOULEVARD

SANTA MONICA, CA, 90404